SCHEMBL16616707

SCHEMBL16616707

COC(=O)c1ccc(CC(C(C)=O)C(=O)OC)c(OC)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.48
KMT2A Q03164 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.43
MEN1 O00255 3/20 0.43
HSD17B2 P37059 1/20 0.43
TSHR P16473 1/20 0.43
ALDH1A1 P00352 1/20 0.42
KDM4E B2RXH2 1/20 0.41
POLB P06746 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
MGLL Q99685 1/20 0.40
NPC1 O15118 1/20 0.40
PKM P14618 1/20 0.40
RAB9A P51151 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40
XDH P47989 1/20 0.40
CA9 Q16790 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL853782 0.91 HSD17B2 (0.49) MAPTKMT2ASMN1; SMN2MEN1HSD17B2
SCHEMBL15390848 0.89 CA12 (0.50) MAPTSMN1; SMN2TSHRALDH1A1KDM4E
SCHEMBL15305553 0.83 EPHX1 (0.44) MAPTKMT2ASMN1; SMN2MEN1ALDH1A1
SCHEMBL6122016 0.82 PYCR1 (0.43) MAPTKMT2ASMN1; SMN2MEN1ALDH1A1
SCHEMBL8251185 0.81 MAPT (0.54) MAPTKMT2ASMN1; SMN2MEN1HSD17B2
SCHEMBL20212292 0.81 ALDH1A1 (0.56) MAPTKMT2ASMN1; SMN2MEN1HSD17B2
SCHEMBL30036817 0.81 ALDH1A1 (0.56) MAPTKMT2ASMN1; SMN2MEN1HSD17B2
SCHEMBL8732462 0.80 MAPT (0.53) MAPTKMT2ASMN1; SMN2MEN1HSD17B2
SCHEMBL31295843 0.79 ACACB (0.39) MAPTKMT2AMEN1ALDH1A1
SCHEMBL27942554 0.79 MTNR1A (0.51) KMT2AMEN1TSHRALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12077510-B2 Carboxylic acid compounds Sumitomo Pharma Co., Ltd. (JP) 2024-09-03 US disclosed
US-20220267282-A1 CARBOXYLIC ACID COMPOUNDS SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2022-08-25 US disclosed
US-11299465-B2 Carboxylic acid compounds SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2022-04-12 US disclosed
US-20200317623-A1 CARBOXYLIC ACID COMPOUNDS SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2020-10-08 US disclosed
US-10562861-B2 Carboxylic acid compounds SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2020-02-18 US disclosed
US-20190119220-A1 CARBOXYLIC ACID COMPOUNDS SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2019-04-25 US disclosed
US-10150743-B2 Carboxylic acid compounds SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2018-12-11 US disclosed
EP-2850067-B1 CARBOXYLIC ACID COMPOUNDS SUMITOMO DAINIPPON PHARMA CO LTD (JP) 2017-08-16 EP disclosed
US-20160251319-A1 CARBOXYLIC ACID COMPOUNDS SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2016-09-01 US disclosed
US-9376398-B2 Carboxylic acid compounds SUMITOMO DAINIPPON PHARMA CO., LTD (JP) 2016-06-28 US disclosed
US-20150099770-A1 CARBOXYLIC ACID COMPOUNDS Sumitomo Pharma Co., Ltd. (JP) 2015-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150099770-A1 CARBOXYLIC ACID COMPOUNDS C9, SUCNR1, C3AR1 MAPT 4427/4885KMT2A 2031/4885SMN1; SMN2 1872/4885
US-20160251319-A1 CARBOXYLIC ACID COMPOUNDS C9, SUCNR1, C3AR1 MAPT 4427/4885KMT2A 2031/4885SMN1; SMN2 1872/4885
US-10150743-B2 Carboxylic acid compounds C9, C3AR1, SUCNR1 MAPT 4403/4885KMT2A 1870/4885SMN1; SMN2 1895/4885
US-12077510-B2 Carboxylic acid compounds C9, C3AR1, SUCNR1 MAPT 4403/4885KMT2A 1870/4885SMN1; SMN2 1895/4885
US-20200317623-A1 CARBOXYLIC ACID COMPOUNDS C9, C3AR1, SUCNR1 MAPT 4403/4885KMT2A 1870/4885SMN1; SMN2 1895/4885
US-20190119220-A1 CARBOXYLIC ACID COMPOUNDS C9, C3AR1, SUCNR1 MAPT 4403/4885KMT2A 1870/4885SMN1; SMN2 1895/4885
US-11299465-B2 Carboxylic acid compounds C9, C3AR1, SUCNR1 MAPT 4403/4885KMT2A 1870/4885SMN1; SMN2 1895/4885
US-20220267282-A1 CARBOXYLIC ACID COMPOUNDS C9, C3AR1, SUCNR1 MAPT 4403/4885KMT2A 1870/4885SMN1; SMN2 1895/4885
US-10562861-B2 Carboxylic acid compounds C9, C3AR1, SUCNR1 MAPT 4403/4885KMT2A 1870/4885SMN1; SMN2 1895/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.